Key points are not available for this paper at this time.
By describing what is known about these pathways, this review highlights key areas for future research that would contribute to the understanding and clinical treatment of non-nutritional diseases of hypophosphatemia, particularly XLH.
Beck‐Nielsen et al. (Tue,) studied this question.